◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...

Appili Therapeutics Inc.

Financial Statements (IFRS) · Amounts in CAD
5 10 All
Income Statement
Balance Sheet
Cash Flow
Line Item FY 2025Mar 31, 2025 FY 2024Mar 31, 2024 FY 2023Mar 31, 2023 FY 2022Mar 31, 2022 FY 2021Mar 31, 2021
Total Revenue 100,443 827,407 334,177 1.4M --
Operating Revenue 100,443 827,407 334,177 1.4M --
Selling General And Administration 2.9M 3.0M 4.4M 4.6M --
General And Administrative Expense 2.9M 3.0M 4.4M 4.6M --
Research And Development 7.3M 5.8M 3.8M 21.5M --
Other Operating Expenses -9.9M -5.9M -138,466 -1.1M --
Operating Expense 291,282 3.0M 8.1M 25.0M --
Operating Income -190,839 -2.2M -7.8M -23.6M --
EBIT 347,106 -2.1M -8.1M -23.5M --
Interest Expense 3.0M 1.6M 1.1M 1.6M --
Interest Expense Non Operating 3.0M 1.6M 1.1M 1.6M --
Interest Income 36.00 16,812 29,882 33,730 --
Interest Income Non Operating 36.00 16,812 29,882 33,730 --
Net Interest Income -3.5M -1.6M -1.1M -1.5M --
Other Income Expense 1.1M 65,656 -364,606 56,817 --
Other Non Operating Income Expenses 1.4M -- -- -- --
Gain On Sale Of Security -329,154 65,656 -364,606 56,817 --
Pretax Income -2.6M -3.7M -9.2M -25.1M --
Tax Provision 18,830 69,583 36,392 38,459 --
Tax Effect Of Unusual Items -49,373 9,848 -145,842 14,892 --
Net Income From Continuing And Discontinued Operation -2.6M -3.8M -9.2M -25.1M --
Net Income From Continuing Operation Net Minority Interest -2.6M -3.8M -9.2M -25.1M --
Net Income Including Noncontrolling Interests -2.6M -3.8M -9.2M -25.1M --
Net Income Common Stockholders -2.6M -3.8M -9.2M -25.1M --
Net Income -2.6M -3.8M -9.2M -25.1M --
EBITDA 360,566 -2.1M -8.1M -23.5M --
Normalized EBITDA 689,720 -2.1M -7.7M -23.6M --
Reconciled Depreciation 13,460 13,662 6,266 12,643 --
Basic EPS -0.02 -0.03 -0.08 -0.38 --
Diluted EPS -0.02 -0.03 -0.08 -0.38 --
Basic Average Shares 121.3M 121.3M 113.7M 66.7M --
Diluted Average Shares 121.3M 121.3M 113.7M 66.7M --
Total Unusual Items -329,154 65,656 -364,606 56,817 --
Total Unusual Items Excluding Goodwill -329,154 65,656 -364,606 56,817 --
Tax Rate For Calcs 0.15 0.15 0.40 0.26 --
Normalized Income -2.3M -3.8M -9.0M -25.2M --
Diluted NI Availto Com Stockholders -2.6M -3.8M -9.2M -25.1M --
Net Income Continuous Operations -2.6M -3.8M -9.2M -25.1M --
Net Non Operating Interest Income Expense -3.5M -1.6M -1.1M -1.5M --
Other Gand A 2.9M 3.0M 4.4M 4.6M --
Total Expenses 291,282 3.0M 8.1M 25.0M --
Total Other Finance Cost 547,914 -- -- -- --
Line Item FY 2025Mar 31, 2025 FY 2024Mar 31, 2024 FY 2023Mar 31, 2023 FY 2022Mar 31, 2022 FY 2021Mar 31, 2021
Cash And Cash Equivalents 1.2M 94,493 2.5M 6.7M --
Cash Cash Equivalents And Short Term Investments 1.2M 94,493 2.5M 6.7M --
Cash Financial 1.2M 94,493 2.5M 6.7M --
Other Short Term Investments -- -- -- 0.00 5.1M
Receivables 1.7M 1.2M 420,784 1.4M --
Inventory -- -- -- -- 0.00
Prepaid Assets 114,514 192,433 231,099 183,546 --
Current Assets 3.0M 1.5M 3.1M 8.2M --
Gross PPE -- 82,837 55,547 125,569 137,289
Accumulated Depreciation -- -52,695 -40,937 -83,322 -82,296
Net PPE 19,043 30,142 14,610 42,247 --
Total Non Current Assets 19,043 30,142 14,610 42,247 --
Total Assets 3.0M 1.5M 3.1M 8.3M --
Current Debt 11.6M 7.3M 113,125 95,555 --
Current Debt And Capital Lease Obligation 11.6M 7.3M 113,125 95,555 --
Accounts Payable 4.1M 4.2M 2.8M 6.5M --
Payables 4.1M 4.2M 2.9M 6.5M --
Payables And Accrued Expenses 4.1M 4.2M 2.9M 6.5M --
Other Current Liabilities -- -- -- 117,627 --
Current Liabilities 15.7M 11.5M 3.0M 6.7M --
Long Term Debt 736,100 875,200 7.6M 4.9M --
Long Term Debt And Capital Lease Obligation 736,100 875,200 7.6M 4.9M --
Total Non Current Liabilities Net Minority Interest 736,100 875,200 7.6M 4.9M --
Total Liabilities Net Minority Interest 16.4M 12.4M 10.5M 11.6M --
Common Stock 42.3M 42.3M 42.3M 39.7M --
Capital Stock 42.3M 42.3M 42.3M 39.7M --
Additional Paid In Capital 14.8M 12.9M 6.4M 5.0M --
Retained Earnings -71.7M -69.1M -65.3M -56.1M --
Common Stock Equity -13.4M -10.9M -7.4M -3.3M --
Stockholders Equity -13.4M -10.9M -7.4M -3.3M --
Total Equity Gross Minority Interest -13.4M -10.9M -7.4M -3.3M --
Total Capitalization -12.7M -10.0M 155,241 1.6M --
Net Tangible Assets -13.4M -10.9M -7.4M -3.3M --
Tangible Book Value -13.4M -10.9M -7.4M -3.3M --
Working Capital -12.7M -10.1M 140,631 1.6M --
Invested Capital -1.1M -2.7M 268,366 1.7M --
Total Debt 12.3M 8.2M 7.7M 5.0M --
Net Debt 11.1M 8.1M 5.2M -- --
Share Issued 121.3M 121.3M 121.3M 71.3M --
Ordinary Shares Number 121.3M 121.3M 121.3M 71.3M --
Machinery Furniture Equipment -- 44,969 40,525 38,972 50,692
Other Current Borrowings -- -- -- -- 85,300
Other Equity Interest 1.2M 3.0M 9.2M 8.1M --
Other Properties -- 37,868 15,022 86,598 86,597
Other Receivables 1.6M 1.1M 69,006 40,738 --
Raw Materials -- -- -- -- 0.00
Taxes Receivable 71,540 86,610 351,778 1.4M --
Total Tax Payable 29,471 47,149 41,008 0.00 --
Line Item FY 2025Mar 31, 2025 FY 2024Mar 31, 2024 FY 2023Mar 31, 2023 FY 2022Mar 31, 2022 FY 2021Mar 31, 2021
Operating Cash Flow 868,816 -2.5M -10.1M -19.1M --
Cash Flow From Continuing Operating Activities 868,816 -2.5M -10.1M -19.1M --
Depreciation And Amortization 13,460 13,662 6,266 12,643 --
Depreciation Amortization Depletion 13,460 13,662 6,266 12,643 --
Stock Based Compensation 117,802 191,346 875,124 2.0M --
Change In Working Capital -226,192 661,442 -3.2M 2.5M --
Changes In Account Receivables -500,338 -1.0M 346,694 568,279 --
Change In Receivables -497,538 -752,551 970,294 295,079 --
Change In Inventory -- -- -- 0.00 39,198
Change In Payables And Accrued Expense 193,427 1.4M -4.2M 1.9M --
Other Non Cash Items 3.4M 485,576 1.1M 1.6M --
Capital Expenditure -2,360 -29,717 -3,175 -- -8,448
Purchase Of PPE -2,360 -29,717 -3,175 0.00 --
Net PPE Purchase And Sale -2,360 -29,063 -3,175 0.00 --
Purchase Of Investment -- -- -- 0.00 -20.0M
Sale Of Investment -- -- 0.00 5.1M 15.0M
Net Investment Purchase And Sale -- -- 0.00 5.1M -5.0M
Investing Cash Flow -2,360 -29,063 -3,175 5.1M --
Cash Flow From Continuing Investing Activities -2,360 -29,063 -3,175 5.1M --
Issuance Of Debt 400,000 300,000 2.5M 8.0M --
Repayment Of Debt -141,816 -96,423 -85,600 -4.2M --
Net Issuance Payments Of Debt 258,184 203,577 2.4M 3.8M --
Issuance Of Capital Stock -- 0.00 3.2M 5.3M 13.1M
Net Common Stock Issuance -- 0.00 3.2M 5.3M 13.1M
Financing Cash Flow 193,683 122,045 5.9M 9.6M --
Cash Flow From Continuing Financing Activities 193,683 122,045 5.9M 9.6M --
Effect Of Exchange Rate Changes 73,612 54.00 -6,378 56,817 --
Changes In Cash 1.1M -2.4M -4.2M -4.5M --
Beginning Cash Position 94,493 2.5M 6.7M 11.1M --
End Cash Position 1.2M 94,493 2.5M 6.7M --
Free Cash Flow 866,456 -2.5M -10.1M -19.1M --
Income Tax Paid Supplemental Data -- 62,601 12,417 -- --
Interest Paid Supplemental Data -- 1.1M 476,267 93,005 24,626
Cash Dividends Paid 0.00 0.00 0.00 0.00 --
Change In Prepaid Assets 77,919 38,666 -47,553 267,468 --
Common Stock Issuance -- 0.00 3.2M 5.3M 13.1M
Depreciation 13,460 13,662 6,266 12,643 --
Gain Loss On Sale Of PPE 0.00 -131.00 24,546 103.00 --
Interest Paid Cff -64,501 -72,521 -83,377 -93,005 --
Long Term Debt Issuance 400,000 300,000 2.5M 8.0M --
Long Term Debt Payments -141,816 -96,423 -85,600 -4.2M --
Net Foreign Currency Exchange Gain Loss 170,109 -35,410 378,747 -57,564 --
Net Income From Continuing Operations -2.6M -3.8M -9.2M -25.1M --
Net Long Term Debt Issuance 258,184 203,577 2.4M 3.8M --
Net Other Financing Charges -- -9,011 -922,607 -1.2M -1.4M
Operating Gains Losses 170,109 -35,541 403,293 -57,461 --
Proceeds From Stock Option Exercised -- 0.00 1.3M 1.7M 5.4M
Sale Of PPE 0.00 654.00 0.00 -- --
NEWS
Loading news...
TRENDING
Loading...